While this is an important step as will the uplisting in the US I don't think we see a huge bump today.

When we hit the real milestones laid out for clinical progress and movement toward freezing design, completion of CE clearance, etc the access to the additional capital and institutions uplisting gives the company will be vital. I do believe this sets us up for a great fourth quarter/early part of 2015 with milestones ahead.

I could be wrong, I hope I am but not losing sleep if this doesn't pop today

BelizeMe

Titan Medical Inc. Announces Receipt of Final Approval to Graduate to TSX
TORONTO, ONTARIO--(Marketwired - Sept. 29, 2014) - Titan Medical Inc. ("Titan" or the "Company")(TSX VENTURE:TMD) (OTCQX:TITXF) today announced that, effective at market opening on September 30, 2014, Titan's common shares and warrants will commence trading on the Toronto Stock Exchange ("TSX"). Concurrent with the TSX listing, the Company's common shares and warrants will be de-listed from the TSX Venture Exchange.
John Hargrove, Titan's Chairman and Chief Executive Officer, commented, "As the TSX is one of the world's leading stock exchanges, we are pleased to have achieved this milestone. The TSX Venture Exchange has served us extremely well as the platform for the first phase of our capital markets strategy. We believe that our listing on the senior stock exchange will enhance our company's visibility and will provide increased access to capital markets and a more diverse investor base."
The trading symbols and CUSIP / ISIN numbers for Titan's common shares and listed warrants will remain unchanged.
About Titan Medical Inc.

Ryan071236,

I appreciate your take on single port and your belief that it will only be a niche' market. It it true that SILS has taken longer to break out than most thought. If you went to any gyn, gen, or uro meeting over the last 5 yrs it seemed the main push was on SILS.
The main reason for this was the instrumentation. It was almost impossible and NOT intutive (sorry for the I word) for surgeon to operate the flexible, rotating tipped instrumentation that some manufacturers came out with. Only the best coordinated, and that does not always translate into best surgeon clinically could use two of these instruments at once. They only could use one along with one standard straight stick instrument.
What SPORT will do with the improvement of the robotics will allow them to much more easily operate both instruments at once and in much greater degrees. Those that already use da' vinci will have a very easy transition to single port and those new to robotic lap surgery will have no longer a learning curve than those training on da'vinci and I would argue even easier as you are only working with two vs. four arms. Set-up will aslo be multiple times easier and faster for staff and surgeons.
So if you believe robotics will continue to grow expedentially as costs decrease SPORT is in a very good position.
I am sure there will be cases where a hospital will bring in the add-n SILS from Intuitive if they already have a newer system but there will also be a strong business case made that still does not answer the problem of immobility for the da' vinci. We don't know the price of the SILS add on for Intuitive. If expensive the case may be made that you could have two robots, one being SPORT and one da' vinci that could be operating at the same time and increasing hospital revenue more efficiently.
In regards to the PPS only getting to $20 in the next 3-5 yrs I wouln't be in it if I believed that. Also not sure why you think Stryker would be the one to acquire.... becuase they overpaid for Mako Surgical at a share price that was an 86 percent premium over its trading price the day before the deal was announced? There are many companies, medium and large that could be players and would seemingly over pay for an acquisition of Titan. Covidien acquired New Wave surgical for 5 x revenue and many early investors made 30-40 times their investments. As I have said, I do not believe Titan will get acquired before an FDA clearance and launch in the US. This takes ALL the risk of the table for an acquiring company and will make price much higher. At that early point you can't use simple calculations based solely on sales for a price, it is as much about "how much do you want me" as others certainly will. I believe they will take the route of a Mako; Clearance, Limited launch in US, expand several times..... and then see where they are as far as goals for selling. Over this time we may see some of the executives cash out and change based on their career stage or goals and new blood brought in with extensive experience to continue growth.
BelizeME

I don't post often but this board needs some fact on certain points based info from someone who has 25 yrs in surgical devices, 11 yrs. at national and regional sales director roles and the last 9 yrs in start-ups in MIS lap surgery, including robotic. It cracks me up that those that post 20 messages a day feel this gives them some credibility.

1) There will be NO reverse split. Stop raising it. Management is of the conservative nature which is proven everyday. They are focused on milestones and release info when they are accomplished. No interest in manipulating daily stock price. I am confident they are fully aware that the key milestones in the next 6 months will get them organically to levels needed for uplist and greater institutional involvement.

2) On the topic of going it alone or M/A and the the fact that Titan currently has no sales force.

- As far as the sales force those who keep saying that Titan should be currently or soon building up and training a sales force in US ahead of FDA clearance this is 100% wrong and shows a lack of understanding of how to launch a new surgical device. As approval gets close there will be additional management hires such as a VP of Sales, Director of Clinical Training, etc. They will do strategic planning for a limited launch. No reps will be hired prior to a launch. What rep would leave a company before a company has a product to sell. The launch will be limited to keep control and make sure things run smoothly with no mistakes. The team can grow fairly quickly as needed to respond to needs.

- The assumption that only a large organization such as Covidien, J&J, etc could handle this product because they already have large sales forces. WRONG. This is a specialized device that would need a completely new sales force with ANY organization. Just because a company has an accomplished sales team for MIS lap surgery does not mean they could or would ever have any involvement with SPORT.

3) Merger vs. Acquisition - No one knows what the medium or long-term goals are with Titan in this regard. I can tell you that there will be no M/A before FDA Clearance. Titan knows what they have and are not going to sell until the milestones and clearances get the PPS up. If any M/A happens it will be a full acquistion. If the party who is looking for M/A has the pockets to purchase Titan they would do so as outright purchase. There is no value for the acquirer to do merger or licensing deal and drag out acquistion as the buyout price would just grow as sales mount. It could also bring in other players into the mix and while they may have final bid per an agreement it could make the price much higher.

4) IP and lawsuits - Please stop the hype that Titan needs a big player in the mix with deep pockets to fend off inevitable lawsuits with Intuitive. This is nonsense. Frivalous lawsuits in the med-device space are rare. The IP lawyers will have protected the organization with strong patents that do not infringe Intuitive. By the way, if there was a IP lawsuit it could just easily come from Titan.

5) Pumpers on this board - Those who claim they have inside info should just go away. If you did and you were posting that fact you are breaking enough laws to put you in prison. All of your devices would be seized and your communications with any "insider" would be found. Just stop, it's embarrasing. And if someone was giving you ANY info they are losers and only hurting the company. They are also breaking the law as anyone that would have access to the technology or any REAL timelines would have signed a non-disclosure agreement. To those that say they got a letter from an attorney telling them to cease and decist from diclosing info...BS. IF you did get a letter it was to tell you to stop posting false info in hopes of manipulating stock.

I attended the national SLS meeting last week and Intuitive was not displaying any single port application in any form even though they have FDA clearance. While it would be nice to get to market ahead of this product line extension in the end it will have little impact either way.

For those that say they are long on Titan and hope for an acquisistion by end of year at $10 .....that is NOT LONG. I have been in for over 3 yrs, have over 170,000 shares and warrants and will not sell a single share for at least two years. IMO Titan PPS will get to $30-$40 in next 18 months. That is when it starts to get interesting!

BelizeME

Do you practice at Portsmouth?

While I don't believe your info is credible, curious why you deleted the post from yesterday that said you bought additional shares based on insider info? Don't worry, it's not lost, I took a screen shot.

Point,

Thanks for your article on Titan. Great job. I also saw you corrected spelling of haptic. Thx.

I did want to put out there that I have some concerns with putting out a valuation estimates in the range of $7-$10 PPS. Without sales it would only be an exercise and not hold a lot of value.

I personally believe from over 20 yrs. experience in surgical devices and the last 9 in surgical start-ups that it will be significantly higher once the first clearance for CE is approved. This will be a true momentum stock from that point through FDA clearance and into the first year of sales. I would estimate a run up to ~ $35 PPS with FDA clearance.

While most of the time I would agree any PR is good PR, something that I believe paints a lower upside could dissuade potential small and medium individual investors such as myself. I currently have a little over 170,000 shares if you include my warrants which I will exercise at the appropriate time. I do not think the article would affect institutional buyers either way as they have their own calculations and ways of doing due diligence.

As I said, I do appreciate your efforts but I wanted to voice my concern regarding any articles on valuations of share price before any market approvals or sales.

I purchased add'l shares/warrants in Jan offering to add to my position. Holding strong at > 170,000 shares when I exercise warrants.

Good news would be welcome on 21st but in it for longer term gain with CE and FDA clearances and launches. I believe that will put Titan in ~ $35 range.

Hi,

I am new to posting on the board, however I have followed for over two years. I have a very large position in TITXF and have positions from 50 cents to 1.28.

I viewed the video for Intuitive's SP and wanted to pass along some thoughts that I hope will temper some of the nervous posts I am seeing.

Two of the major advantages for Titan's SPORT are the lower cost, almost a third of Intuitive's new Xi device which the SP will be paired with and its targeted approval for general surgery and the large number of Chole's.

Nothing here has changed. The Intuitive SP will still be over two million dollars, will not be able to go room to room or operate in outpatient centers, and is only FDA cleared for urology. It will also not be ready for commercialization unit mid 2015 after clearing other reg hurdles to work with the new Xi.

Hope this helps those suffering heart palpatations!!